The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer
Article in Journal of Experimental & Clinical Cancer Research (June 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells
Article in Journal of Translational Medicine (May 2024)
Exploring the physiological role of the G protein-coupled estrogen receptor (GPER) and its associations with human diseases
Article in Psychoneuroendocrinology (May 2024)